142 related articles for article (PubMed ID: 36661708)
1. Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.
Zhai Y; Chopra P; Kang D; Robert NJ; Zhang W
Curr Oncol; 2023 Jan; 30(1):769-785. PubMed ID: 36661708
[TBL] [Abstract][Full Text] [Related]
2. Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.
Mynard N; Saxena A; Mavracick A; Port J; Lee B; Harrison S; Chow O; Villena-Vargas J; Scheff R; Giaccone G; Altorki N
Clin Lung Cancer; 2022 May; 23(3):e238-e242. PubMed ID: 34580031
[TBL] [Abstract][Full Text] [Related]
3. Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic.
Mayne NR; Bajaj SS; Powell J; Elser HC; Civiello BS; Fintelmann FJ; Li X; Yang CJ
Clin Lung Cancer; 2022 Sep; 23(6):e362-e376. PubMed ID: 35660355
[TBL] [Abstract][Full Text] [Related]
4. Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation.
Strohbehn GW; Holleman R; Burns J; Klamerus ML; Kelley MJ; Kerr EA; Ramnath N; Hofer TP
JAMA Oncol; 2022 Nov; 8(11):1663-1667. PubMed ID: 36136314
[TBL] [Abstract][Full Text] [Related]
5. Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.
Crvenkova S; Jakimovki D; Ristovski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):105-115. PubMed ID: 36987767
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.
Ksienski D; Gupta S; Truong PT; Bone J; Chan A; Alex D; Hart J; Pollock P; Patterson T; Clarkson M; Dissanayake D; Sonke E; Lesperance M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2951-2961. PubMed ID: 35834010
[TBL] [Abstract][Full Text] [Related]
7. Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community Controls.
Arrato NA; Lo SB; Coker CA; Covarrubias JJ; Blevins TR; Reisinger SA; Presley CJ; Shields PG; Andersen BL
J Natl Compr Canc Netw; 2022 Feb; 20(2):118-125. PubMed ID: 35130505
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 pandemic on lung cancer patients.
Sha Z; Chang K; Mi J; Liang Z; Hu L; Long F; Shi H; Lin Z; Wang X; Pei X
Ann Palliat Med; 2020 Sep; 9(5):3373-3378. PubMed ID: 33065788
[TBL] [Abstract][Full Text] [Related]
9. Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival.
Mayne NR; Elser HC; Darling AJ; Raman V; Liou DZ; Colson YL; D'Amico TA; Yang CJ
Ann Surg; 2021 May; 273(5):850-857. PubMed ID: 33630435
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer During the COVID-19 Pandemic.
Hijmering-Kappelle LBM; Hiltermann TJN; Bensch F
Clin Lung Cancer; 2022 Mar; 23(2):143-150. PubMed ID: 35034861
[TBL] [Abstract][Full Text] [Related]
11. Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis.
Carroll R; Bortolini M; Calleja A; Munro R; Kong S; Daumont MJ; Penrod JR; Lakhdari K; Lacoin L; Cheung WY
BMC Cancer; 2022 Mar; 22(1):255. PubMed ID: 35264135
[TBL] [Abstract][Full Text] [Related]
12. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
13. An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic.
Moffat GT; Hanna L; Hopman W; Fung AS; Gaudreau PO
Immunotherapy; 2023 Aug; 15(12):921-932. PubMed ID: 37431608
[TBL] [Abstract][Full Text] [Related]
14. The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration Datasets.
Gysling S; Morgan H; Ifesemen OS; West D; Conibear J; Navani N; O'Dowd EL; Baldwin DR; Humes D; Hubbard R
Chest; 2023 Jun; 163(6):1599-1607. PubMed ID: 36640995
[TBL] [Abstract][Full Text] [Related]
15. Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.
Jones L; Rittberg R; Leung B; Shokoohi A; Pender A; Wong S; Al-Hashami Z; Wang Y; Ho C
Curr Oncol; 2022 Nov; 29(11):8686-8692. PubMed ID: 36421338
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic.
Olesen TB; Rasmussen TR; Jakobsen E; Engberg H; Hilberg O; Møller H; Jensen JW; Jensen H
Cancer Epidemiol; 2023 Aug; 85():102373. PubMed ID: 37172520
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study.
Nadler E; Arondekar B; Aguilar KM; Zhou J; Chang J; Zhang X; Pawar V
J Cancer Res Clin Oncol; 2021 Mar; 147(3):671-690. PubMed ID: 33263865
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients.
Arak H; Eronat O; Dogan I; Aydin ES; Aytekin A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1271-1277. PubMed ID: 37926880
[TBL] [Abstract][Full Text] [Related]
19. Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience and Insights Gained During the COVID-19 Pandemic.
West HJ; Tan YA; Barzi A; Wong D; Parsley R; Sachs T
JCO Oncol Pract; 2022 Apr; 18(4):e537-e550. PubMed ID: 34860558
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey.
Bailey H; Lee A; Eccles L; Yuan Y; Burlison H; Forshaw C; Varol N
BMC Cancer; 2023 Jun; 23(1):603. PubMed ID: 37386452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
